First-Line Treatment of HER2-Positive Metastatic Breast Cancer
2 مناظر
• 07/03/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے